In the latest study, researchers at McGill University in Montreal found that Metformin, a commonly used drug to treat type-2 diabetes, increases the risk of low thyroid-stimulating hormone level in patients with underactive thyroids. In this study, 74,300 patients were given either Metformin or sulfonylurea, over a 25-year study period. In patients with treated hypothyroidism, Metformin monotherapy was linked with 55% increased risk of low TSH levels as compared to the use of sulfonuylurea. Via Science World Report. Posted September 26, 2014.
Alanna McCatty is founder and CEO of McCatty Scholars, an organization that devises and implements financial literacy programs for students to combat the nationwide issue of the loss of educational opportunity due to the ramifications of burdensome student debt. At MedShadow, she reports on new findings and research on the side effects of prescription drugs. She is a graduate of Pace University.
Did you find this article helpful?
No votes so far! Be the first to rate this post.